No Data
No Data
Enfusion, Inc. (NYSE:ENFN) Might Not Be As Mispriced As It Looks
With a median price-to-sales (or "P/S") ratio of close to 4.7x in the Software industry in the United States, you could be forgiven for feeling indifferent about Enfusion, Inc.'s (NYSE:ENFN) P/S
Enfusion Announces Date of Second Quarter 2024 Results
Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced it will release its second quarter 2024 financial results before the
Insider Sale: Chief People Officer Bronwen Bastone Sells Shares of Enfusion Inc (ENFN)
Form 144 | Enfusion(ENFN.US) Officer Proposes to Sell 147.9K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 20, $Enfusion(ENFN.US)$ Officer Bastone Bronwen intends to sell 18,241 shares of its common stock on Jun 20, with a total market value of approximately $147.9K. Bastone B
FTV Capital Expands Internationally With Opening of London Office
As part of the expansion, Richard Earnshaw joins as partner to lead new office and FTV's European investing efforts alongside growing team FTV Capital, a prominent sector-focused growth equity investment firm with a
Morgan Stanley Maintains Enfusion(ENFN.US) With Buy Rating, Maintains Target Price $11
Morgan Stanley analyst Michael Infante maintains $Enfusion(ENFN.US)$ with a buy rating, and maintains the target price at $11.According to TipRanks data, the analyst has a success rate of 0.0% and a t